Letter

Thrombolysis in patients with diabetes

BMJ 1995; 310 doi: 10.1136/bmj.310.6985.1008a (Published 15 April 1995)
Cite this as: BMJ 1995;310:1008.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

More evidence that the treatment should not necessarily be withheld

  1. D K Newman,
  2. M P Snead,
  3. D W Flanagan,
  4. J D Scott
  1. Registrar in ophthalmology Senior registrar in ophthalmology Consultant ophthalmologist Consultant ophthalmologist Department of Ophthalmology, Addenbrooke's Hospital, Cambridge CB2 2QQ

    EDITOR,—Helen Ward and John S Yudkin rightly draw attention to the lack of evidence that thrombolytic treatment for acute myocardial infarction may precipitate vitreous haemorrhage in patients with diabetic retinopathy.1 Two additional points strengthen their argument that the treatment should not necessarily be withheld in such patients.

    Firstly, consideration of the pathophysiology of diabetic vitreous haemorrhage …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular